These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1320706)

  • 1. New fluorescent probes E3810 and methoxy E3810 for determining distributions of the apical membrane and the acidic compartment of gastric acid secreting cells.
    Takeguchi N; Yamanouchi T; Sakai H; Morii M
    Jpn J Physiol; 1992; 42(1):75-88. PubMed ID: 1320706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
    Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
    Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor.
    Morii M; Takata H; Fujisaki H; Takeguchi N
    Biochem Pharmacol; 1990 Feb; 39(4):661-7. PubMed ID: 2154989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
    Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase.
    Morii M; Hamatani K; Takeguchi N
    Biochem Pharmacol; 1995 Jun; 49(12):1729-34. PubMed ID: 7598734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y; Morii M; Takeguchi N
    Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
    Nochi S; Yokoyama Y; Narukawa M; Ebine K; Murahashi M; Kawakami Y; Asakawa N; Sato T
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):552-8. PubMed ID: 8882453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
    Morii M; Takeguchi N
    J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization of gastric histamine during repeated administration of a proton potassium adenosine triphosphatase inhibitor in intact and antrectomized rats.
    Miyazaki Y; Shinomura Y; Higashimoto Y; Imamura I; Fukui H; Aoki T; Okuda Y; Narita T; Miwa K; Miyazaki I
    Regul Pept; 1995 Jul; 58(1-2):47-54. PubMed ID: 8570859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
    Im WB; Sih JC; Blakeman DP; McGrath JP
    J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sulphoxide moiety of substituted benzimidazoles is essential for inhibition of parietal cell K+/H+-ATPase.
    Beil W; Eltze M; Heintze K; Klemm K; Riedel R; Schudt C; Sewing KF; Simon A
    Br J Pharmacol; 1986 Jun; 88(2):389-95. PubMed ID: 3015311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
    Nagaya H; Inatomi N; Nohara A; Satoh H
    Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisecretagogues and parietal cells.
    Sewing KF
    Agents Actions; 1984 Apr; 14(3-4):319-24. PubMed ID: 6328950
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action of omeprazole.
    Wallmark B
    Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors.
    Sih JC; Im WB; Robert A; Graber DR; Blakeman DP
    J Med Chem; 1991 Mar; 34(3):1049-62. PubMed ID: 1848293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomeric regulation of gastric H+,K+-ATPase.
    Morii M; Hayata Y; Mizoguchi K; Takeguchi N
    J Biol Chem; 1996 Feb; 271(8):4068-72. PubMed ID: 8626741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.